mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy - PubMed (original) (raw)

mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy

D E Selley et al. Mol Pharmacol. 1997 Jan.

Abstract

G protein activation by different mu-selective opioid agonists was examined in rat thalamus, SK-N-SH cells, and mu-opioid receptor-transfected mMOR-CHO cells using agonist-stimulated guanosine-5'-O-(gamma-thio)-triphosphate ([35S]GTP gamma S) binding to membranes in the presence of excess GDP. [D-Ala2, N-MePhe4, Gly5-ol]Enkephalin (DAMGO) was the most efficacious agonist in rat thalamus and SK-N-SH cells, followed by (in rank order) fentanyl = morphine > > buprenorphine. In mMOR-CHO cells expressing a high density of mu receptors, no differences were observed among DAMGO, morphine or fentanyl, but these agonists were more efficacious than buprenorphine, which was more efficacious than levallorphan. In all three systems, efficacy differences were magnified by increasing GDP concentrations, indicating that the activity state of G proteins can affect agonist efficacy. Scatchard analysis of net agon stimulated [35S]GTP gamma S binding revealed two major components responsible for agonist efficacy differences. First, differences in the KD values of agonist-stimulated [35S]GTP gamma S binding between high efficacy agonists (DAMGO, fentanyl, and morphine) and classic partial agonists (buprenorphine and levallorphan) were observed in all three systems. Second, differences in the Bmax value of agonist-stimulated [35S]GTP gamma S binding were observed between DAMGO and morphine or fentanyl in rat thalamus and SK-N-SH cells and between the high efficacy agonists and buprenorphine or levallorphan in all three systems. These results suggest that mu-opioid agonist efficacy is determined by the magnitude of the receptor-mediated affinity shift in the binding of GTP (or[35S]GTP gamma S) versus GDP to the G protein and by the number of G proteins activated per occupied receptor.

PubMed Disclaimer

Cited by

Role of µ-opioid receptor reserve and µ-agonist efficacy as determinants of the effects of µ-agonists on intracranial self-stimulation in rats.
Altarifi AA, Miller LL, Negus SS. Altarifi AA, et al. Behav Pharmacol. 2012 Oct;23(7):678-92. doi: 10.1097/FBP.0b013e328358593c. Behav Pharmacol. 2012. PMID: 22914074 Free PMC article.
Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor.
Lu JJ, Polgar WE, Mann A, Dasgupta P, Schulz S, Zaveri NT. Lu JJ, et al. Mol Pharmacol. 2021 Jul;100(1):7-18. doi: 10.1124/molpharm.120.000076. Epub 2021 May 6. Mol Pharmacol. 2021. PMID: 33958480 Free PMC article.
Differential activation of G-proteins by mu-opioid receptor agonists.
Saidak Z, Blake-Palmer K, Hay DL, Northup JK, Glass M. Saidak Z, et al. Br J Pharmacol. 2006 Mar;147(6):671-80. doi: 10.1038/sj.bjp.0706661. Br J Pharmacol. 2006. PMID: 16415903 Free PMC article.
Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF. Narita M, et al. Br J Pharmacol. 1999 Jan;126(2):451-6. doi: 10.1038/sj.bjp.0702330. Br J Pharmacol. 1999. PMID: 10077238 Free PMC article.
Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment.
Allouche S, Le Marec T, Coquerel A, Noble F, Marie N. Allouche S, et al. Psychopharmacology (Berl). 2015 May;232(9):1527-33. doi: 10.1007/s00213-014-3785-x. Epub 2014 Oct 31. Psychopharmacology (Berl). 2015. PMID: 25358852

mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy - PubMed (original) (raw)